Navigation Links
Boehringer Ingelheim Announces Equine Research Awards
Date:12/3/2012

ell as seasonality of Corynebacterium pseudotuberculosis infection and studies of insect vectors.

The topic for the 2013 awards will be announced next spring. Veterinarians, diagnosticians, and public and private researchers in the United States and Canada are eligible to submit proposals. Awards will be selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies.

"I am encouraged by the quality of the proposals submitted this year," Dr. Grubbs says. "BIVI is proud to take a leading role in helping provide equine health solutions, but we would not be nearly as successful without the ongoing research conducted by dedicated research and veterinary medical professionals around the country."

For more information and complete submission instructions, please visit www.equinediseaseresearch.com.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expen
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
2. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
3. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
4. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
5. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
6. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
7. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
8. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
11. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in ... released bipartisan discussion draft called "21 st Century ... planned to be taken up by Congress soon and ... and medical device products are developed and marketed in ... reason, many companies have begun to consider how the ...
(Date:4/17/2015)... April 17, 2015  AbbVie Inc. ("AbbVie") (NYSE / CHX ... has extended the expiration of its exchange offer to acquire ... Inc. to 5 p.m., New York City ... April 17, 2015, AbbVie also voluntarily withdrew its initial Notification ... order to provide the FTC with additional time to review ...
(Date:4/17/2015)... MINNEAPOLIS , April 17, 2015 Nonin ... announced that President and Chief Operating Officer Steve ... Philip Isaacson is expanding his role as Chief ... his role as Chief Technology Officer. Operations will transition ... " Steve Bucholz has been instrumental to ...
Breaking Medicine Technology:21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2
... AVIV, Israel, May 8, 2012  InspireMD, Inc. (OTC BB: ... focusing on the development and commercialization of its proprietary ... Myocardial Infarctions, today announced financial results for the quarter ... Co-Founder and CEO of InspireMD, said: "The quarter was ...
... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported a ... the first quarter of 2012 compared to a pro forma ... The Company ended the first quarter of 2012 with nearly ... we have had multiple important accomplishments.  Our partners at Genzyme ...
Cached Medicine Technology:InspireMD Announces First Quarter 2012 Financial Results 2InspireMD Announces First Quarter 2012 Financial Results 3InspireMD Announces First Quarter 2012 Financial Results 4InspireMD Announces First Quarter 2012 Financial Results 5InspireMD Announces First Quarter 2012 Financial Results 6InspireMD Announces First Quarter 2012 Financial Results 7Isis Reports Financial Results and Highlights for First Quarter 2012 2Isis Reports Financial Results and Highlights for First Quarter 2012 3Isis Reports Financial Results and Highlights for First Quarter 2012 4Isis Reports Financial Results and Highlights for First Quarter 2012 5Isis Reports Financial Results and Highlights for First Quarter 2012 6Isis Reports Financial Results and Highlights for First Quarter 2012 7Isis Reports Financial Results and Highlights for First Quarter 2012 8Isis Reports Financial Results and Highlights for First Quarter 2012 9
(Date:4/18/2015)... More than 2000 styles of newly ... the #1 online store carrying celebrity inspired special occasion ... got their perfect dresses for their prom. For those ... dresses at TheCelebrityDresses.com would be an ideal choice. ... prom dresses inspired by the most loved styles seen ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch ... at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... , In a turbulent world, people may find themselves ... always be their first move, but some situations can be ...
(Date:4/17/2015)... 2015 Heritage Woods of McLeansboro, a ... Living Week Celebration on April 20 with a day ... mind, body and soul. , The community, which is ... older adults of all incomes, including those on Medicaid, ... Supportive Living Week is observed every April and highlights ...
(Date:4/17/2015)... WA (PRWEB) April 17, 2015 ERGO-Pedic ... cushions is introducing two new products to help a ... low back pain relief are the second most common ... our first product, designed specifically to help relieve sitting ... Comfort Cushion, and thousands of happy customers later, we ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital ... Carrollwood were all selected as Top Workplaces in Tampa ... County, is ranked number one for large businesses according ... conducted in partnership with an independent research firm. Florida ... that opened in October of 2012 with a vision ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4
... ... state’s first, privately owned platinum LEED certified office park to be located ... this classification in Sussex County and is in keeping with the Counties ... Lewes will be hosting the yearly Sustainable Delaware conference.,Planned as a 45,000 ...
... MedTouch, ... President to head Client Services, Sandra Fancher , ... (PRWEB) June 28, 2010 -- MedTouch today ... Fancher will work closely with our award winning healthcare clients developing interactive strategies. , ...
... ... HIV-Contaminated Needles Being Reused in Developing Countries or Washing Up on Coastal Shores , ... Mission Viejo, California (Vocus) June 28, ... quest to end death and suffering caused by accidental needlesticks and global reuse of contaminated ...
... Mild cognitive impairment is often seen as a transition ... the more serious problems of Alzheimer,s disease. But ... Rush University Medical Center have found that lower, though ... or retention and processing speed in motor tasks dependent ...
... development of an infant,s brain can leave behind fingerprints. ... in learning how these fingerprints can predict future behavioral ... even autism. New U of I research shows that ... discovered that neonatal piglets are capable of being trained ...
... gas bubbles and sound waves is to be developed at ... drugs to be delivered in small doses directly to tumours, ... If successful, the technique could easily be adapted for other ... cancer specialists from across the University to work on the ...
Cached Medicine News:Health News:Ocean Park – Delaware's First Privately Owned Platinum LEED Certified Office Park 2Health News:Ocean Park – Delaware's First Privately Owned Platinum LEED Certified Office Park 3Health News:MedTouch Makes Senior Staff Appointment 2Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 2Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 3Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 4Health News:Memory problems not the only predictor of later mild cognitive impairment 2Health News:Piglets open doors to study infant brain development 2Health News:Piglets open doors to study infant brain development 3Health News:Bursting bubbles with sound offers new treatments for cancer 2Health News:Bursting bubbles with sound offers new treatments for cancer 3
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-1000...
LH EIA Reproductive Markers 025-BC-1031 Luteinizing Hormone...
... important androgen secreted into the blood. In ... cells of the testes; in females ca. ... conversion of androstenedione, ca. 25% from the ... glands. The Testosterone ELISA KIT is based ...
Microalbumin EIA Lipid / Protein Quantification 024-IDC-12...
Medicine Products: